⌘K

Home/Filings/4/0001618835-20-000028

4//SEC Filing

Culwell Kelly 4

Accession 0001618835-20-000028

CIK 0001618835other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 2:10 PM ET

Size

4.8 KB

Accession

0001618835-20-000028

Insider Transaction Report

Form 4

Period: 2020-02-19

Evofem Biosciences, Inc.EVFM

Chief Medical Officer

Transactions

Sale
Common Stock
2020-02-19$7.00/sh−1,000$7,000→ 196,226 total

Footnotes (1)

[F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.

Documents

1 file

4
wf-form4_158231222323693.xmlPrimary
FORM 4

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1

filerCIK 0001726183

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 2:10 PM ET
Size: 4.8 KB

View on SEC.gov